Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Other Income / Expenses history
Currency unavailable · from the income statement
No Other Income / Expenses data reported for this period type.
Other Income / Expenses vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $30.53M USD | +82.8% | — | — |
| LTM Jun 2026 | $26M USD | -12.8% | +93.5% | 9.2% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $18.29M USD | -91.0% | +350.3% | 247.2% |
| LTM Mar 2026 | $10.82M USD | -0.5% | +57.2% | 129.3% | |
| LTM Mar 2026 | $5.35M USD | +16.3% | — | — | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | €1.76M EUR | -90.8% | — | — |
| LTM Sep 2026 | -$13.69M USD | -121.2% | +303.0% | 15.1% | |
| LTM Mar 2026 | -$67.43M USD | -67.3% | — | 29.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -40.1% | +198.3% | 29.0% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.